m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00357)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
TP63
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Methyltransferase-like 3 (METTL3) [WRITER]
Representative RNA-seq result indicating the expression of this target gene regulated by METTL3 | ||
Cell Line | mouse embryonic stem cells | Mus musculus |
Treatment: METTL3-/- ESCs
Control: Wild type ESCs
|
GSE145309 | |
Regulation |
|
logFC: 4.35E+00 p-value: 1.15E-34 |
More Results | Click to View More RNA-seq Results | |
Representative RIP-seq result supporting the interaction between TP63 and the regulator | ||
Cell Line | MDA-MB-231 | Homo sapiens |
Regulation | logFC: 6.67E+00 | GSE60213 |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | METTL3 knock down and methylation inhibitor cycloleucine could decrease the m6A levels and the expression of DeltaNp63 in Cutaneous squamous cell carcinoma. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Cutaneous squamous cell carcinoma | ICD-11: 2C31.Z | ||
Pathway Response | Signaling pathways regulating pluripotency of stem cells | hsa04550 | ||
Cell Process | Cell proliferation | |||
In-vitro Model | A-431 | Skin squamous cell carcinoma | Homo sapiens | CVCL_0037 |
HSC-1 | Skin squamous cell carcinoma | Homo sapiens | CVCL_2807 | |
In-vivo Model | 2 × 106 cells were suspended in 150 uL DMEM. The A431 cells (scrambled group and shRNA1 group) were injected subcutaneously into the flanks of nude mice. | |||
Lung cancer [ICD-11: 2C25]
Cutaneous squamous cell carcinoma [ICD-11: 2C31]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | METTL3 knock down and methylation inhibitor cycloleucine could decrease the m6A levels and the expression of DeltaNp63 in Cutaneous squamous cell carcinoma. | |||
Responsed Disease | Cutaneous squamous cell carcinoma [ICD-11: 2C31.Z] | |||
Target Regulator | Methyltransferase-like 3 (METTL3) | WRITER | ||
Target Regulation | Up regulation | |||
Pathway Response | Signaling pathways regulating pluripotency of stem cells | hsa04550 | ||
Cell Process | Cell proliferation | |||
In-vitro Model | A-431 | Skin squamous cell carcinoma | Homo sapiens | CVCL_0037 |
HSC-1 | Skin squamous cell carcinoma | Homo sapiens | CVCL_2807 | |
In-vivo Model | 2 × 106 cells were suspended in 150 uL DMEM. The A431 cells (scrambled group and shRNA1 group) were injected subcutaneously into the flanks of nude mice. | |||